Pure speculation on your part.Status of 3D manufacturing - pure speculation on your part. The company could easily generate 10,000 doses as they did for the CHF trial ( 9000 doses worth ) Thats almost 200 million in profit.
Pretty sure when they ask lonza for more cells using 3d reactors, the cost is not going to be 200 million... but also pretty sure given they already made 9000 doses for chf, a figure like 20-000 could be achieved using 2d easily.
Talking a billion in revenue at that stage.
CLBP is the block buster.
easiest administration
lowest number of cells of any treatment ( 25 times less than chf / gvhd)
competitive price
long lasting effect.
2024 Here we go again., page-260
-
- There are more pages in this discussion • 402 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59782 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 26617 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |